Comment on Chun et al, “A Randomized Phase II Study of Perioperative Chemotherapy Plus Bevacizumab Versus Postoperative Chemotherapy Plus Bevacizumab in Patients With Upfront Resectable Hepatic Colorectal Metastases” / Gelsomino, F., Spallanzani, A., Casadei Gardini, A.. - In: CLINICAL COLORECTAL CANCER. - ISSN 1533-0028. - 19:4(2020), pp. e262-e263. [10.1016/j.clcc.2020.06.002]
Comment on Chun et al, “A Randomized Phase II Study of Perioperative Chemotherapy Plus Bevacizumab Versus Postoperative Chemotherapy Plus Bevacizumab in Patients With Upfront Resectable Hepatic Colorectal Metastases”
Casadei Gardini A.
2020-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
